Call for Abstract

3rd International Conference and Exhibition on Cell & Gene Therapy, will be organized around the theme “Uncover the potential that lies within the cell”

Cell Therapy-2014 is comprised of 12 tracks and 81 sessions designed to offer comprehensive sessions that address current issues in Cell Therapy-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Anti-ageing therapies
  • Track 1-2Gemmotherapy
  • Track 1-3Multipurpose plant stem cells
  • Track 1-4Stem cells applications in cosmetics longevity
  • Track 1-5Plant extracts & commercial uses
  • Track 1-6New era in plant stem cell technology
  • Track 2-1Stem cell propagation techniques
  • Track 2-2Plant genetics
  • Track 2-3Mineral balance via stem cell therapies
  • Track 2-4Plant Stem cells & transgenics
  • Track 2-5Genetically modified plants
  • Track 2-6Hormonal therapy with stem cells
  • Track 3-1Molecular therapy
  • Track 3-2Ocular therapy
  • Track 3-3Neuro therapy for neurological diseases
  • Track 3-4Cardiac cell therapy
  • Track 3-5Cell therapies for renal failure
  • Track 3-6RNA therapeutics
  • Track 3-7Virotherapy
  • Track 4-1Molecular basis of pluripotency
  • Track 4-2Bone marrow stem cells as therapy
  • Track 4-3Current views of the embryonic & neural stem cells
  • Track 4-4Stem cell therapy for genetic disorders
  • Track 4-5Targeting stem cells for therapeutic benefits
  • Track 4-6Transplantation technologies in stem cell therapy
  • Track 5-1Cell replacement therapy
  • Track 5-2Potential uses of defined cell populations
  • Track 5-3Reprogramming cell fate
  • Track 5-4Role of molecular markers in therapies
  • Track 5-5Target tissues & routes of delivery
  • Track 5-6Causes of regenerative failure
  • Track 6-1Tumor suppressor genes
  • Track 6-2Biomarkers involved in gene therapy
  • Track 6-3Genetic screening & diagnostics
  • Track 6-4Cloning & expression systems
  • Track 6-5Mobile genetic elements
  • Track 6-6Vectors for gene therapy
  • Track 6-7Cellular & organismal genetic engineering
  • Track 6-8Gene transfer to induce cellular programming
  • Track 6-9Therapies for genetic disorders/autoimmune disorders
  • Track 6-10Molecular basis of epigenetics
  • Track 7-1Cell based immunotherapy
  • Track 7-2Cancers of immune cells
  • Track 7-3New cell therapies for allergies
  • Track 7-4Cell based immunosuppression in transplantation
  • Track 7-5Tumour cells evade/defeat immune system
  • Track 7-6Bio-Immune cellular therapy
  • Track 8-1Stem cells & cancer treatments
  • Track 8-2Characteristics of cancer cells
  • Track 8-3Cell cycle & oncology
  • Track 8-4Modern approaches in molecular cancer therapeutics
  • Track 8-5Genomics & cancer drug resistance
  • Track 8-6Cancer stem cells as a valuable target for diagnostic and therapy
  • Track 8-7Genetically engineered cancer vaccines
  • Track 8-8Therapeutic cancer vaccines
  • Track 8-9Challenges & risks of cancer gene therapy
  • Track 9-1Nano methods to target cancer cells
  • Track 9-2Nano-microfluidics in cell therapy
  • Track 9-3Nano materials and nano engineering
  • Track 9-4Pros & cons of molecular manufacturing
  • Track 9-5Nanovaccines
  • Track 10-1Biomedical engineering
  • Track 10-2Developing new probes for tissue targeting
  • Track 10-3Therapeutic bioengineering
  • Track 10-4Cellular mechanobiology
  • Track 10-5Tissue engineering from own stem cells
  • Track 10-6Current understanding & challenges in bioprocessing
  • Track 10-7Bioengineering for medical diagnostics and imaging
  • Track 11-1Principles of gene therapy & clinical gene therapy
  • Track 11-2Animal & human trials of engineered tissues
  • Track 11-3Emerging clinical aspects of stem cell therapy
  • Track 11-4Pharmacogenomics in cell therapy
  • Track 11-5Clinical trial design and analysis
  • Track 11-6Clinical genetics
  • Track 11-7Alternative lab models for therapeutic applications
  • Track 12-1Commercialization strategy
  • Track 12-2Ethics involved in human stem cells
  • Track 12-3Logistics in preparing lab models for cell therapy applications
  • Track 12-4Innovative therapeutic technologies
  • Track 12-5Manufacturing of cell therapy products and marketing guidelines
  • Track 12-6FDA & EMA guidelines